The abluminal endothelial membrane in neurovascular remodeling in health and disease

Science Signaling

Volumn 5, Issue 236, 2012, Pages

  Hermann, Dirk M ^a   ElAli, Ayman ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ABLUMINAL ENDOTHELIAL MEMBRANE; ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN BLOOD VESSEL; BRAIN DISEASE; BRAIN INJURY; CELL POLARITY; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; MEMBRANE; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ASTROCYTES; BLOOD-BRAIN BARRIER; BRAIN; BRAIN DISEASES; ENDOTHELIAL CELLS; EXTRACELLULAR MATRIX; HUMANS; MODELS, BIOLOGICAL; PERICYTES; SIGNAL TRANSDUCTION;

EID: 84864880815     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.2002886     Document Type: Review

References (125)

1. E. H. Lo, T. Dalkara, M. A. Moskowitz, Mechanisms, challenges and opportunities in stroke. Nat. Rev. Neurosci. 4, 399-415 (2003).
2. D. M. Hermann, M. Chopp, Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation. Lancet Neurol. 11, 369-380 (2012).
3. B. V. Zlokovic, Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat. Rev. Neurosci. 12, 723-738 (2011).
4. G. Bazzoni, E. Dejana, Endothelial cell-to-cell junctions: Molecular organization and role in vascular homeostasis. Physiol. Rev. 84, 869-901 (2004).
5. B. T. Hawkins, T. P. Davis, The blood-brain barrier/ neurovascular unit in health and disease. Pharmacol. Rev. 57, 173-185 (2005).
6. N. J. Abbott, L. Rönnbäck, E. Hansson, Astrocyteendothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 7, 41-53 (2006).
7. W. Löscher, H. Potschka, Drug resistance in brain diseases and the role of drug effl ux transporters. Nat. Rev. Neurosci. 6, 591-602 (2005).
8. D. M. Hermann, C. L. Bassetti, Implications of ATP-binding cassette transporters for brain pharmacotherapies. Trends Pharmacol. Sci. 28, 128- 134 (2007).
9. A. Spudich, E. Kilic, H. Xing, U. Kilic, K. M. Rentsch, H. Wunderli-Allenspach, C. L. Bassetti, D. M. Hermann, Inhibition of multidrug resistance transporter-1 facilitates neuroprotective therapies after focal cerebral ischemia. Nat. Neurosci. 9, 487-488 (2006).
10. E. Kilic, A. Spudich, U. Kilic, K. M. Rentsch, R. Vig, C. M. Matter, H. Wunderli-Allenspach, J. M. Fritschy, C. L. Bassetti, D. M. Hermann, ABCC1: A gateway for pharmacological compounds to the ischaemic brain. Brain 131, 2679-2689 (2008).
11. A. ElAli, D. M. Hermann, ATP-binding cassette transporters and their roles in protecting the brain. Neuroscientist 17, 423-436 (2011).
12. K. Gaengel, G. Genové, A. Armulik, C. Betsholtz, Endothelial-mural cell signaling in vascular development and angiogenesis. Arterioscler. Thromb. Vasc. Biol. 29, 630-638 (2009).
13. S. Liebner, C. J. Czupalla, H. Wolburg, Current concepts of blood-brain barrier development. Int. J. Dev. Biol. 55, 467-476 (2011).
14. R. D. Bell, E. A. Winkler, A. P. Sagare, I. Singh, B. LaRue, R. Deane, B. V. Zlokovic, Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. Neuron 68, 409-427 (2010).
15. M. Hellström, M. Kalén, P. Lindahl, A. Abramsson, C. Betsholtz, Role of PDGF-B and PDGFRbeta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 126, 3047-3055 (1999).
16. A. Abramsson, P. Lindblom, C. Betsholtz, Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and infl uence vascular pattern formation in tumors. J. Clin. Invest. 112, 1142-1151 (2003).
17. E. A. Winkler, R. D. Bell, B. V. Zlokovic, Central nervous system pericytes in health and disease. Nat. Neurosci. 14, 1398-1405 (2011).
18. H. Mi, H. Haeberle, B. A. Barres, Induction of astrocyte differentiation by endothelial cells. J. Neurosci. 21, 1538-1547 (2001).
19. E. Dejana, The role of wnt signaling in physiological and pathological angiogenesis. Circ. Res. 107, 943-952 (2010).
20. G. J. del Zoppo, R. Milner, Integrin-matrix interactions in the cerebral microvasculature. Arterioscler. Thromb. Vasc. Biol. 26, 1966-1975 (2006).
21. H. B. Chun, M. Scott, S. Niessen, H. Hoover, A. Baird, J. Yates 3rd, B. E. Torbett, B. P. Eliceiri, The proteome of mouse brain microvessel membranes and basal lamina. J. Cereb. Blood Flow Metab. 31, 2267-2281 (2011).
22. B. Engelhardt, L. Sorokin, The blood-brain and the blood-cerebrospinal fl uid barriers: Function and dysfunction. Semin. Immunopathol. 31, 497- 511 (2009).
23. T. Osada, Y. H. Gu, M. Kanazawa, Y. Tsubota, B. T. Hawkins, M. Spatz, R. Milner, G. J. del Zoppo, Interendothelial claudin-5 expression depends on cerebral endothelial cell-matrix adhesion by β(1)-integrins. J. Cereb. Blood Flow Metab. 31, 1972-1985 (2011).
24. A. N. Stratman, K. M. Malotte, R. D. Mahan, M. J. Davis, G. E. Davis, Pericyte recruitment during vasculogenic tube assembly stimulates endothelial basement membrane matrix formation. Blood 114, 5091-5101 (2009).
25. K. M. Baeten, K. Akassoglou, Extracellular matrix and matrix receptors in blood-brain barrier formation and stroke. Dev. Neurobiol. 71, 1018-1039 (2011).
26. A. Soontornmalai, M. L. Vlaming, J. M. Fritschy, Differential, strain-specifi c cellular and subcellular distribution of multidrug transporters in murine choroid plexus and blood-brain barrier. Neuroscience 138, 159-169 (2006).
27. D. H. Dobrogowska, A. W. Vorbrodt, Quantitative immunocytochemical study of blood-brain barrier glucose transporter (GLUT-1) in four regions of mouse brain. J. Histochem. Cytochem. 47, 1021- 1030 (1999).
28. S. Vemula, K. E. Roder, T. Yang, G. J. Bhat, T. J. Thekkumkara, T. J. Abbruscato, A functional role for sodium-dependent glucose transport across the blood-brain barrier during oxygen glucose deprivation. J. Pharmacol. Exp. Ther. 328, 487-495 (2009).
29. R. Hallmann, D. N. Mayer, E. L. Berg, R. Broermann, E. C. Butcher, Novel mouse endothelial cell surface marker is suppressed during differentiation of the blood brain barrier. Dev. Dyn. 202, 325-332 (1995).
30. R. Daneman, L. Zhou, D. Agalliu, J. D. Cahoy, A. Kaushal, B. A. Barres, The mouse blood-brain barrier transcriptome: a new resource for understanding the development and function of brain endothelial cells. PLoS ONE 5, e13741 (2010).
31. A. Rosell, E. H. Lo, Multiphasic roles for matrix metalloproteinases after stroke. Curr. Opin. Pharmacol. 8, 82-89 (2008).
32. M. Yepes, B. D. Roussel, C. Ali, D. Vivien, Tissuetype plasminogen activator in the ischemic brain: More than a thrombolytic. Trends Neurosci. 32, 48-55 (2009).
33. A. G. Arroyo, M. L. Iruela-Arispe, Extracellular matrix, infl ammation, and the angiogenic response. Cardiovasc. Res. 86, 226-235 (2010).
34. R. Polavarapu, M. C. Gongora, H. Yi, S. Ranganthan, D. A. Lawrence, D. Strickland, M. Yepes, Tissue-type plasminogen activator-mediated shedding of astrocytic low-density lipoprotein receptorrelated protein increases the permeability of the neurovascular unit. Blood 109, 3270-3278 (2007).
35. M. Yemisci, Y. Gursoy-Ozdemir, A. Vural, A. Can, K. Topalkara, T. Dalkara, Pericyte contraction induced by oxidative-nitrative stress impairs capillary refl ow despite successful opening of an occluded cerebral artery. Nat. Med. 15, 1031-1037 (2009).
36. E. Dejana, E. Tournier-Lasserve, B. M. Weinstein, The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications. Dev. Cell 16, 209-221 (2009).
37. X. Wang, S. R. Lee, K. Arai, S. R. Lee, K. Tsuji, G. W. Rebeck, E. H. Lo, Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator. Nat. Med. 9, 1313-1317 (2003).
38. A. P. Lillis, L. B. Van Duyn, J. E. Murphy-Ullrich, D. K. Strickland, LDL receptor-related protein 1: unique tissue-specifi c functions revealed by selective gene knockout studies. Physiol. Rev. 88, 887-918 (2008).
39. K. Benchenane, V. Berezowski, C. Ali, M. Fernán-dez- Monreal, J. P. López-Atalaya, J. Brillault, J. Chuquet, A. Nouvelot, E. T. MacKenzie, G. Bu, R. Cecchelli, O. Touzani, D. Vivien, Tissue-type plasminogen activator crosses the intact blood-brain barrier by low-density lipoprotein receptor-related protein-mediated transcytosis. Circulation 111, 2241-2249 (2005).
40. B. V. Zlokovic, R. Deane, A. P. Sagare, R. D. Bell, E. A. Winkler, Low-density lipoprotein receptorrelated protein-1: A serial clearance homeostatic mechanism controlling Alzheimer's amyloid β-peptide elimination from the brain. J. Neurochem. 115, 1077-1089 (2010).
41. D. Gveric, R. Hanemaaijer, J. Newcombe, N. A. van Lent, C. F. Sier, M. L. Cuzner, Plasminogen activators in multiple sclerosis lesions: implications for the infl ammatory response and axonal damage. Brain 124, 1978-1988 (2001).
42. S. S. Jung, W. Zhang, W. E. Van Nostrand, Pathogenic Aβ induces the expression and activation of matrix metalloproteinase-2 in human cerebrovascular smooth muscle cells. J. Neurochem. 85, 1208-1215 (2003).
43. P. C. Brooks, A. M. Montgomery, M. Rosenfeld, R. A. Reisfeld, T. Hu, G. Klier, D. A. Cheresh, Integrin α v β 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79, 1157-1164 (1994).
44. D. G. Stupack, X. S. Puente, S. Boutsaboualoy, C. M. Storgard, D. A. Cheresh, Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins. J. Cell Biol. 155, 459-470 (2001).
45. R. Milner, I. L. Campbell, Developmental regulation of beta1 integrins during angiogenesis in the central nervous system. Mol. Cell. Neurosci. 20, 616-626 (2002).
46. J. Wang, R. Milner, Fibronectin promotes brain capillary endothelial cell survival and proliferation through αn;5β1 and alphavbeta3 integrins via MAP kinase signalling. J. Neurochem. 96, 148-159 (2006).
47. W. Risau, V. Lemmon, Changes in the vascular extracellular matrix during embryonic vasculogenesis and angiogenesis. Dev. Biol. 125, 441- 450 (1988).
48. R. Milner, S. Hung, B. Erokwu, P. Dore-Duffy, J. C. LaManna, G. J. del Zoppo, Increased expression of fi bronectin and the α 5 β 1 integrin in angiogenic cerebral blood vessels of mice subject to hypobaric hypoxia. Mol. Cell. Neurosci. 38, 43-52 (2008).
49. E. B. Carson-Walter, J. Hampton, E. Shue, D. M. Geynisman, P. K. Pillai, R. Sathanoori, S. L. Madden, R. L. Hamilton, K. A. Walter, Plasmalemmal vesicle associated protein-1 is a novel marker implicated in brain tumor angiogenesis. Clin. Cancer Res. 11, 7643-7650 (2005).
50. A. ElAli, D. M. Hermann, Apolipoprotein E controls ATP-binding cassette transporters in the ischemic brain. Sci. Signal. 3, ra72 (2010).
51. S. S. Reddy, T. E. Connor, E. J. Weeber, W. Rebeck, Similarities and differences in structure, expression, and functions of VLDLR and ApoER2. Mol. Neurodegener. 6, 30 (2011).
52. W. Stockinger, C. Brandes, D. Fasching, M. Hermann, M. Gotthardt, J. Herz, W. J. Schneider, J. Nimpf, The reelin receptor ApoER2 recruits JNKinteracting proteins-1 and -2. J. Biol. Chem. 275, 25625-25632 (2000).
53. D. Bächner, D. Schröder, N. Betat, M. Ahrens, G. Gross, Apolipoprotein E (ApoE), a Bmp-2 (bone morphogenetic protein) upregulated gene in mesenchymal progenitors (C3H10T1/2), is highly expressed in murine embryonic development. Biofactors 9, 11-17 (1999).
54. C. P. Yang, J. A. Gilley, G. Zhang, S. G. Kernie, ApoE is required for maintenance of the dentate gyrus neural progenitor pool. Development 138, 4351-4362 (2011).
55. K. Aoki, T. Uchihara, N. Sanjo, A. Nakamura, K. Ikeda, K. Tsuchiya, Y. Wakayama, Increased expression of neuronal apolipoprotein E in human brain with cerebral infarction. Stroke 34, 875-880 (2003).
56. Y. S. Li, J. H. Haga, S. Chien, Molecular basis of the effects of shear stress on vascular endothelial cells. J. Biomech. 38, 1949-1971 (2005).
57. S. McCue, D. Dajnowiec, F. Xu, M. Zhang, M. R. Jackson, B. L. Langille, Shear stress regulates forward and reverse planar cell polarity of vascular endothelium in vivo and in vitro. Circ. Res. 98, 939-946 (2006).
58. P. Cirone, S. Lin, H. L. Griesbach, Y. Zhang, D. C. Slusarski, C. M. Crews, A role for planar cell polarity signaling in angiogenesis. Angiogenesis 11, 347-360 (2008).
59. E. K. Vladar, D. Antic, J. D. Axelrod, Planar cell polarity signaling: the developing cell's compass. Cold Spring Harb. Perspect. Biol. 1, a002964 (2009).
60. R. Bayly, J. D. Axelrod, Pointing in the right direction: New developments in the fi eld of planar cell polarity. Nat. Rev. Genet. 12, 385-391 (2011).
61. V. A. de Jesus Perez, T. P. Alastalo, J. C. Wu, J. D. Axelrod, J. P. Cooke, M. Amieva, M. Rabinovitch, Bone morphogenetic protein 2 induces pulmonary angiogenesis via Wnt-β-catenin and Wnt- RhoA-Rac1 pathways. J. Cell Biol. 184, 83-99 (2009).
62. B. Descamps, R. Sewduth, N. Ferreira Tojais, B. Jaspard, A. Reynaud, F. Sohet, P. Lacolley, C. Allières, J. M. Lamazière, C. Moreau, P. Dufourcq, T. Couffinhal, C. Duplàa, Frizzled 4 regulates arterial network organization through noncanonical Wnt/planar cell polarity signaling. Circ. Res. 110, 47-58 (2012).
63. I. P. Laumanns, L. Fink, J. Wilhelm, J. C. Wolff, R. Mitnacht-Kraus, S. Graef-Hoechst, M. M. Stein, R. M. Bohle, W. Klepetko, M. A. Hoda, R. T. Schermuly, F. Grimminger, W. Seeger, R. Voswinckel, The noncanonical WNT pathway is operative in idiopathic pulmonary arterial hypertension. Am. J. Respir. Cell Mol. Biol. 40, 683-691 (2009).
64. C. Gao, Y. G. Chen, Dishevelled: The hub of Wnt signaling. Cell. Signal. 22, 717-727 (2010).
65. G. H. Mahabeleshwar, W. Feng, K. Reddy, E. F. Plow, T. V. Byzova, Mechanisms of integrinvascular endothelial growth factor receptor crossactivation in angiogenesis. Circ. Res. 101, 570- 580 (2007).
66. H. Hall, J. A. Hubbell, Matrix-bound sixth Ig-like domain of cell adhesion molecule L1 acts as an angiogenic factor by ligating alphavbeta3-integrin and activating VEGF-R2. Microvasc. Res. 68, 169-178 (2004).
67. H. Hall, V. Djonov, M. Ehrbar, M. Hoechli, J. A. Hubbell, Heterophilic interactions between cell adhesion molecule L1 and alphavbeta3-integrin induce HUVEC process extension in vitro and angiogenesis in vivo. Angiogenesis 7, 213-223 (2004).
68. W. B. Kiosses, S. J. Shattil, N. Pampori, M. A. Schwartz, Rac recruits high-affi nity integrin alphavbeta3 to lamellipodia in endothelial cell migration. Nat. Cell Biol. 3, 316-320 (2001).
69. Z. Li, E. S. Kim, E. L. Bearer, Arp2/3 complex is required for actin polymerization during platelet shape change. Blood 99, 4466-4474 (2002).
70. H. K. Avraham, T. H. Lee, Y. Koh, T. A. Kim, S. Jiang, M. Sussman, A. M. Samarel, S. Avraham, Vascular endothelial growth factor regulates focal adhesion assembly in human brain micro vascular endothelial cells through activation of the focal adhesion kinase and related adhesion focal tyrosine kinase. J. Biol. Chem. 278, 36661-36668 (2003).
71. S. Li, N. F. Huang, S. Hsu, Mechanotransduction in endothelial cell migration. J. Cell. Biochem. 96, 1110-1126 (2005).
72. N. Boudreau, C. Andrews, A. Srebrow, A. Ravanpay, D. A. Cheresh, Induction of the angiogenic phenotype by Hox D3. J. Cell Biol. 139, 257-264 (1997).
73. C. Myers, A. Charboneau, N. Boudreau, Homeobox B3 promotes capillary morphogenesis and angiogenesis. J. Cell Biol. 148, 343-351 (2000).
74. D. A. Cheresh, D. G. Stupack, Regulation of angiogenesis: apoptotic cues from the ECM. Oncogene 27, 6285-6298 (2008).
75. Z. Wu, H. Guo, N. Chow, J. Sallstrom, R. D. Bell, R. Deane, A. I. Brooks, S. Kanagala, A. Rubio, A. Sagare, D. Liu, F. Li, D. Armstrong, T. Gasiewicz, R. Zidovetzki, X. Song, F. Hofman, B. V. Zlokovic, Role of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer disease. Nat. Med. 11, 959-965 (2005).
76. I. Noguera-Troise, C. Daly, N. J. Papadopoulos, S. Coetzee, P. Boland, N. W. Gale, H. C. Lin, G. D. Yancopoulos, G. Thurston, Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis. Nature 444, 1032-1037 (2006).
77. J. Ridgway, G. Zhang, Y. Wu, S. Stawicki, W. C. Liang, Y. Chanthery, J. Kowalski, R. J. Watts, C. Callahan, I. Kasman, M. Singh, M. Chien, C. Tan, J. A. Hongo, F. de Sauvage, G. Plowman, M. Yan, Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis. Nature 444, 1083- 1087 (2006).
78. M. Hellström, L. K. Phng, J. J. Hofmann, E. Wallgard, L. Coultas, P. Lindblom, J. Alva, A. K. Nilsson, L. Karlsson, N. Gaiano, K. Yoon, J. Rossant, M. L. Iruela-Arispe, M. Kalén, H. Gerhardt, C. Betsholtz, Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis. Nature 445, 776-780 (2007).
79. F. M. Lu, S. E. Lux, Constitutively active human Notch1 binds to the transcription factor CBF1 and stimulates transcription through a promoter containing a CBF1-responsive element. Proc. Natl. Acad. Sci. U.S.A. 93, 5663-5667 (1996).
80. K. Takeshita, M. Satoh, M. Ii, M. Silver, F. P. Limbourg, Y. Mukai, Y. Rikitake, F. Radtke, T. Gridley, D. W. Losordo, J. K. Liao, Critical role of endothelial Notch1 signaling in postnatal angiogenesis. Circ. Res. 100, 70-78 (2007).
81. A. Zacharek, J. Chen, X. Cui, Y. Yang, M. Chopp, Simvastatin increases notch signaling activity and promotes arteriogenesis after stroke. Stroke 40, 254-260 (2009).
82. A. Al Haj Zen, A. Oikawa, M. Bazan-Peregrino, M. Meloni, C. Emanueli, P. Madeddu, Inhibition of delta-like-4-mediated signaling impairs reparative angiogenesis after ischemia. Circ. Res. 107, 283-293 (2010).
83. D. Wågsäter, C. Zhu, H. M. Björck, P. Eriksson, Effects of PDGF-C and PDGF-D on monocyte migration and MMP-2 and MMP-9 expression. Atherosclerosis 202, 415-423 (2009).
84. L. Fredriksson, H. Li, C. Fieber, X. Li, U. Eriksson, Tissue plasminogen activator is a potent activator of PDGF-CC. EMBO J. 23, 3793-3802 (2004).
85. E. J. Su, L. Fredriksson, M. Geyer, E. Folestad, J. Cale, J. Andrae, Y. Gao, K. Pietras, K. Mann, M. Yepes, D. K. Strickland, C. Betsholtz, U. Eriksson, D. A. Lawrence, Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke. Nat. Med. 14, 731-737 (2008).
86. X. Li, M. Tjwa, L. Moons, P. Fons, A. Noel, A. Ny, J. M. Zhou, J. Lennartsson, H. Li, A. Luttun, A. Pontén, L. Devy, A. Bouché, H. Oh, A. Manderveld, S. Blacher, D. Communi, P. Savi, F. Bono, M. Dewerchin, J. M. Foidart, M. Autiero, J. M. Herbert, D. Collen, C. H. Heldin, U. Eriksson, P. Carmeliet, Revascularization of ischemic tissues by PDGFCC via effects on endothelial cells and their progenitors. J. Clin. Invest. 115, 118-127 (2005).
87. X. Hou, A. Kumar, C. Lee, B. Wang, P. Arjunan, L. Dong, A. Maminishkis, Z. Tang, Y. Li, F. Zhang, S. Z. Zhang, P. Wardega, S. Chakrabarty, B. Liu, Z. Wu, P. Colosi, R. N. Fariss, J. Lennartsson, R. Nussenblatt, J. S. Gutkind, Y. Cao, X. Li, PDGFCC blockade inhibits pathological angiogenesis by acting on multiple cellular and molecular targets. Proc. Natl. Acad. Sci. U.S.A. 107, 12216- 12221 (2010).
88. B. Z. Qian, J. W. Pollard, Macrophage diversity enhances tumor progression and metastasis. Cell 141, 39-51 (2010).
89. J. Li, Y. N. Kim, P. J. Bertics, Platelet-derived growth factor-stimulated migration of murine fi - broblasts is associated with epidermal growth factor receptor expression and tyrosine phosphorylation. J. Biol. Chem. 275, 2951-2958 (2000).
90. D. G. Gilbertson, M. E. Duff, J. W. West, J. D. Kelly, P. O. Sheppard, P. D. Hofstrand, Z. Gao, K. Shoemaker, T. R. Bukowski, M. Moore, A. L. Feldhaus, J. M. Humes, T. E. Palmer, C. E. Hart, Platelet-derived growth factor C (PDGF-C), a novel growth factor that binds to PDGF α and β receptor. J. Biol. Chem. 276, 27406-27414 (2001).
91. X. Li, A. Kumar, F. Zhang, C. Lee, Y. Li, Z. Tang, P. Arjuna, VEGF-independent angiogenic pathways induced by PDGF-C. Oncotarget 1, 309-314 (2010).
92. P. Lindahl, B. R. Johansson, P. Levéen, C. Betsholtz, Pericyte loss and microaneurysm formation in PDGF-B-defi cient mice. Science 277, 242-245 (1997).
93. A. Armulik, G. Genové, M. Mäe, M. H. Nisancioglu, E. Wallgard, C. Niaudet, L. He, J. Norlin, P. Lindblom, K. Strittmatter, B. R. Johansson, C. Betsholtz, Pericytes regulate the blood-brain barrier. Nature 468, 557-561 (2010).
94. K. A. Ata, F. Lennmyr, K. Funa, Y. Olsson, A. Terént, Expression of transforming growth factor-β1, 2, 3 isoforms and type I and II receptors in acute focal cerebral ischemia: An immunohistochemical study in rat after transient and permanent occlusion of middle cerebral artery. Acta Neuropathol. 97, 447-455 (1999).
95. A. S. Haqqani, M. Nesic, E. Preston, E. Baumann, J. Kelly, D. Stanimirovic, Characterization of vascular protein expression patterns in cerebral ischemia/reperfusion using laser capture microdissection and ICAT-nanoLC-MS/MS. FASEB J. 19, 1809-1821 (2005).
96. K. P. Doyle, E. Cekanaviciute, L. E. Mamer, M. S. Buckwalter, TGFβ signaling in the brain increases with aging and signals to astrocytes and innate immune cells in the weeks after stroke. J. Neuroinfl ammation 7, 62 (2010).
97. C. M. Dubois, M.-H. Laprise, F. Blanchette, L. E. Gentry, R. Leduc, Processing of transforming growth factor β 1 precursor by human furin convertase. J. Biol. Chem. 270, 10618-10624 (1995).
98. J. P. Annes, J. S. Munger, D. B. Rifkin, Making sense of latent TGFbeta activation. J. Cell Sci. 116, 217-224 (2003).
99. S. Cambier, S. Gline, D. Mu, R. Collins, J. Araya, G. Dolganov, S. Einheber, N. Boudreau, S. L. Nishimura, Integrin alpha(v)beta8-mediated activation of transforming growth factor-beta by perivascular astrocytes: An angiogenic control switch. Am. J. Pathol. 166, 1883-1894 (2005).
100. H. Su, H. Kim, L. Pawlikowska, H. Kitamura, F. Shen, S. Cambier, J. Markovics, M. T. Lawton, S. Sidney, A. W. Bollen, P. Y. Kwok, L. Reichardt, W. L. Young, G. Y. Yang, S. L. Nishimura, Reduced expression of integrin alphavbeta8 is associated with brain arteriovenous malformation pathogenesis. Am. J. Pathol. 176, 1018-1027 (2010).
101. F. Li, Y. Lan, Y. Wang, J. Wang, G. Yang, F. Meng, H. Han, A. Meng, Y. Wang, X. Yang, Endothelial Smad4 maintains cerebrovascular integrity by activating N-cadherin through cooperation with Notch. Dev. Cell 20, 291-302 (2011).
102. H. Gerhardt, H. Wolburg, C. Redies, N-cadherin mediates pericytic-endothelial interaction during brain angiogenesis in the chicken. Dev. Dyn. 218, 472-479 (2000).
103. E. Tahinci, C. A. Thorne, J. L. Franklin, A. Salic, K. M. Christian, L. A. Lee, R. J. Coffey, E. Lee, Lrp6 is required for convergent extension during Xenopus gastrulation. Development 134, 4095-4106 (2007).
104. S. Yamamoto, O. Nishimura, K. Misaki, M. Nishita, Y. Minami, S. Yonemura, H. Tarui, H. Sasaki, Cthrc1 selectively activates the planar cell polarity pathway of Wnt signaling by stabilizing the Wnt-receptor complex. Dev. Cell 15, 23-36 (2008).
105. R. J. LeClair, T. Durmus, Q. Wang, P. Pyagay, A. Terzic, V. Lindner, Cthrc1 is a novel inhibitor of transforming growth factor-β signaling and neointimal lesion formation. Circ. Res. 100, 826-833 (2007).
106. S. Liebner, M. Corada, T. Bangsow, J. Babbage, A. Taddei, C. J. Czupalla, M. Reis, A. Felici, H. Wolburg, M. Fruttiger, M. M. Taketo, H. von Melchner, K. H. Plate, H. Gerhardt, E. Dejana, Wnt/β-catenin signaling controls development of the blood-brain barrier. J. Cell Biol. 183, 409-417 (2008).
107. J. M. Stenman, J. Rajagopal, T. J. Carroll, M. Ishibashi, J. McMahon, A. P. McMahon, Canonical Wnt signaling regulates organ-specifi c assembly and differentiation of CNS vasculature. Science 322, 1247-1250 (2008).
108. R. Daneman, D. Agalliu, L. Zhou, F. Kuhnert, C. J. Kuo, B. A. Barres, Wnt/β-catenin signaling is required for CNS, but not non-CNS, angiogenesis. Proc. Natl. Acad. Sci. U.S.A. 106, 641-646 (2009).
109. D. Piccin, C. M. Morshead, Wnt signaling regulates symmetry of division of neural stem cells in the adult brain and in response to injury. Stem Cells 29, 528-538 (2011).
110. T. J. Park, S. L. Haigo, J. B. Wallingford, Ciliogenesis defects in embryos lacking inturned or fuzzy function are associated with failure of planar cell polarity and Hedgehog signaling. Nat. Genet. 38, 303-311 (2006).
111. M. M. Cohen, Jr., Craniofacial anomalies: Clinical and molecular perspectives. Ann. Acad. Med. Singapore 32, 244-251 (2003).
112. M. F. Bijlsma, K. S. Borensztajn, H. Roelink, M. P. Peppelenbosch, C. A. Spek, Sonic hedgehog induces transcription-independent cytoskeletal rearrangement and migration regulated by arachidonate metabolites. Cell. Signal. 19, 2596-2604 (2007).
113. N. Sahir, P. Evrard, P. Gressens, Caffeine induces sonic hedgehog gene expression in cultured astrocytes and neurons. J. Mol. Neurosci. 24, 201- 205 (2004).
114. J. I. Alvarez, A. Dodelet-Devillers, H. Kebir, I. Ifergan, P. J. Fabre, S. Terouz, M. Sabbagh, K. Wosik, L. Bourbonnière, M. Bernard, J. van Horssen, H. E. de Vries, F. Charron, A. Prat, The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence. Science 334, 1727-1731 (2011).
115. T. Nagase, M. Nagase, M. Machida, M. Yamagishi, Hedgehog signaling: a biophysical or biomechanical modulator in embryonic development? Ann. N.Y. Acad. Sci. 1101, 412-438 (2007).
116. A. Ruiz i Altaba, V. Palma, N. Dahmane, Hedge-hog- Gli signalling and the growth of the brain. Nat. Rev. Neurosci. 3, 24-33 (2002).
117. N. M. Amankulor, D. Hambardzumyan, S. M. Pyonteck, O. J. Becher, J. A. Joyce, E. C. Holland, Sonic hedgehog pathway activation is induced by acute brain injury and regulated by injury-related infl ammation. J. Neurosci. 29, 10299-10308 (2009).
118. R. Brewster, J. L. Mullor, A. Ruiz i Altaba, Gli2 functions in FGF signaling during antero-posterior patterning. Development 127, 4395-4405 (2000).
119. J. L. Mullor, N. Dahmane, T. Sun, A. Ruiz i Altaba, Wnt signals are targets and mediators of Gli function. Curr. Biol. 11, 769-773 (2001).
120. B. V. Zlokovic, The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57, 178-201 (2008).
121. S. M. Huang, Y. M. Mishina, S. Liu, A. Cheung, F. Stegmeier, G. A. Michaud, O. Charlat, E. Wiellette, Y. Zhang, S. Wiessner, M. Hild, X. Shi, C. J. Wilson, C. Mickanin, V. Myer, A. Fazal, R. Tomlinson, F. Serluca, W. Shao, H. Cheng, M. Shultz, C. Rau, M. Schirle, J. Schlegl, S. Ghidelli, S. Fawell, C. Lu, D. Curtis, M. W. Kirschner, C. Lengauer, P. M. Finan, J. A. Tallarico, T. Bouwmeester, J. A. Porter, A. Bauer, F. Cong, Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature 461, 614-620 (2009).
122. W. Wang, J. R. Walker, X. Wang, M. S. Tremblay, J. W. Lee, X. Wu, P. G. Schultz, Identifi cation of small-molecule inducers of pancreatic β-cell expansion. Proc. Natl. Acad. Sci. U.S.A. 106, 1427- 1432 (2009).
123. I. Krop, T. Demuth, T. Guthrie, P. Y. Wen, W. P. Mason, P. Chinnaiyan, N. Butowski, M. D. Groves, S. Kesari, S. J. Freedman, S. Blackman, J. Watters, A. Loboda, A. Podtelezhnikov, J. Lunceford, C. Chen, M. Giannotti, J. Hing, R. Beckman, P. Lorusso, Phase I pharmacologic and pharmacodynamic study of the gamma secretase (Notch) inhibitor MK-0752 in adult patients with advanced solid tumors. J. Clin. Oncol. 30, 2307-2313 (2012).
124. B. N. Singh, J. Fu, R. K. Srivastava, S. Shankar, Hedgehog signaling antagonist GDC-0449 (Vismodegib) inhibits pancreatic cancer stem cell characteristics: molecular mechanisms. PLoS ONE 6, e27306 (2011).
125. Q. Ma, B. Huang, N. Khatibi, W. Rolland, 2nd, H. Suzuki, J. H. Zhang, J. Tang, PDGFR-α inhibition preserves blood-brain barrier after intracerebral hemorrhage. Ann. Neurol. 70, 920-931 (2011).